Literature DB >> 28428877

P. aeruginosa colonization at ICU admission as a risk factor for developing P. aeruginosa ICU pneumonia.

Fleur P Paling1, Martin Wolkewitz2, Pieter Depuydt3, Liesbet de Bus3, Frangiscos Sifakis4, Marc J M Bonten1,5, Jan A J W Kluytmans1.   

Abstract

OBJECTIVE: To determine the incidence of P. aeruginosa (PA) ICU pneumonia and its independent association with PA colonization at ICU admission.
METHODS: This was a post-hoc analysis of a prospectively collected cohort study. Adult ICU patients with a length of stay of ≥48 h were included and assessed for microbiologically confirmed PA ICU pneumonia. Multivariate survival analysis was performed, including the covariates age, gender, PA colonization at ICU admission, ICU admission specialty and mechanical ventilation at ICU admission, while taking into account the effect of competing risks.
RESULTS: We included 5093 patients, 2447 (48%) were tested for colonization; of those 226 (9.2%) were PA colonized at ICU admission. The incidence of PA ICU pneumonia was 1.34% (n = 68). PA colonization was an independent risk factor (subdistribution hazard ratio [SHR] 8.8; 95% confidence interval [CI] 4.9-15.7), as was mechanical ventilation (SHR 5.3, 95% CI 2.7-10.6).
CONCLUSION: In this study the incidence of P. aeruginosa ICU pneumonia was 1.34%. Hazard ratios for PA colonized patients compared to non-colonized to develop PA ICU pneumonia were 8.8. The high risk associated with P. aeruginosa colonization for subsequent infection may offer a target for future interventions.

Entities:  

Year:  2017        PMID: 28428877      PMCID: PMC5397688          DOI: 10.1186/s13756-017-0197-9

Source DB:  PubMed          Journal:  Antimicrob Resist Infect Control        ISSN: 2047-2994            Impact factor:   4.887


Introduction

P. aeruginosa (PA) is a frequently occurring nosocomial pathogen, causing potentially life threating infections, one of them being Intensive Care Unit (ICU) pneumonia, or pneumonia acquired while hospitalized on the ICU [1, 2]. PA colonization might be a risk factor for PA ICU pneumonia, but the bacterium may also be an innocent bystander in patients with pneumonia caused by another pathogen [1, 3, 4]. The association between PA carriage on ICU admission and the occurrence of PA ICU pneumonia remains relatively unexplored.

Objective

To estimate the incidence of PA ICU pneumonia and its independent association with PA colonization at ICU admission.

Methods

This analysis was performed on the data of a prospectively collected observational cohort study, performed in a mixed ICU of a tertiary hospital in Belgium. Data on epidemiology of ICU-acquired infections were collected from January 2010 until June 2014, by means of the locally developed COSARA software application, allowing a continuous prospective registration of all infection- and antibiotic-related data [5]. Adult patients with a length of stay of ≥48 h were included; screening for PA was part of routine care in patients with an expected length of stay of ≥48 h and was based on endotracheal aspirate (ETA), oropharyngeal and/or rectal cultures. Pneumonia diagnosis was based on radiologic criteria in combination with at least 1 clinical or laboratory criterion. Confirmed PA ICU pneumonia cases are those with pneumonia occurring ≥48 h after ICU admission and laboratory isolation of PA from any location in the lower respiratory tract. All PA pneumonia diagnoses were cross-validated by trained research physicians. More information on the methods of this analysis are described elsewhere [6]. Patients were regarded as PA colonized at ICU admission if there was a PA positive screening sample or in case of another PA positive respiratory/skin sample on ICU admission ±2 days and if there was no PA infection diagnosed on these days. The incidence density of PA ICU pneumonia was determined using a Cox survival analysis that allows controlling for competing events for the occurrence of ICU pneumonia, in this case ICU discharge/death without ICU pneumonia. The final model yielded subdistribution hazard ratios (SHRs) reflecting the relative effect estimates that account for competing events and the other covariates included in the model. The included covariates were age (as a continuous variable), gender, PA colonization at ICU admission, ICU admission specialty (medical vs. surgical) and mechanical ventilation at ICU admission.

Results

Data were collected from 5093 patients, of whom baseline characteristics can be found in Table 1. A total of 2447 patients (48%) were tested for PA colonization at ICU admission; of those 226 (9.2%) were PA colonized. A total of 675 (13.3) patients developed ICU pneumonia. Microbiologically confirmed PA ICU pneumonia occurred in 68 patients (1.34%). In PA colonized patients PA ICU pneumonia occurred in 9.3% (n = 21); in confirmed non-colonized it occurred in 1.1% (n = 25). The median time to PA ICU pneumonia was 7 days. PA colonization was a risk factor for the development of PA ICU pneumonia with a cause-specific hazard ratio (CSHR) of 9.6 (95% CI 5.3–17.2, p < 0.001). Mechanical ventilation at ICU admission was associated with higher CSHR for developing PA ICU pneumonia (CSHR 2.9; 95% CI 1.4–6.0; p = 0.004). After accounting for competing events, PA colonization at admission remained a risk factor for the development of PA ICU-pneumonia (SHR 8.8, 95% CI 5.0–15.7, p < 0.001, Table 1, Fig. 1), as was mechanical ventilation at ICU admission (SHR 5.3, 95% CI 2.7–10.5, p < 0.001).
Table 1

Baseline characteristics and subdistribution hazard ratio (SHR) for P. aeruginosa ICU pneumonia

N (%) or mean (SD) SHR (95 % CI) p
Gender: femalea 1915 (37.6)0.73 (0.43–1.24)0.24
Ageb 59.4 (16.1)0.99 (0.98–1.01)0.43
Length of stay in days9.1 (11.7)--
 Median5.0
Medical admissionc 2176 (42.7)1.34 (0.82–2.20)0.24
Colonization status at ICU admission
 - PA –2221 (43.6)refref
 - PA +226 (4.4)8.84 (4.96–15.74) <0.001 *
 - Unknown/missing2645 (51.9)1.04 (0.58–1.86)0.89
ICU mortality691 (13.6)--
Mechanical ventilation at ICU admission2591 (50.9)5.2 (2.70–10.47) <0.001 *
ICU pneumonia675 (13.3)--
 - PA68 (1.3)
 - other confirmed pathogen347 (6.8)
 - unknown pathogen260 (5.1)

amale gender is reference category, bSHR per extra year of age, csurgical admission is reference category

*significant at the 0.05 level

- = not measured/not applicable

Fig. 1

Cumulative incidence function. Cumulative risk of acquiring P. aeruginosa ICU pneumonia

Baseline characteristics and subdistribution hazard ratio (SHR) for P. aeruginosa ICU pneumonia amale gender is reference category, bSHR per extra year of age, csurgical admission is reference category *significant at the 0.05 level - = not measured/not applicable Cumulative incidence function. Cumulative risk of acquiring P. aeruginosa ICU pneumonia

Discussion

In this study PA colonized ICU patients with a length of stay of ≥48 h had an almost nine times higher risk of developing PA ICU pneumonia than non-colonized patients. Studies that investigate PA colonization as a risk factor for subsequent PA infection are very scarce, and they do not perform multivariate time-to-event analysis in combination with competing risk analyses [3, 4, 7–9]. This study has several limitations, one of them being a single-center study, another being the fact that only half of the patients were tested for PA colonization at ICU admission. Reasons for not testing included the anticipated short stay on ICU for post-surgical patients. Unfortunately, reasons for admission were not recorded and thus we cannot validate this explanation. A second draw-back is the relatively high number of pneumonias caused by unknown pathogens. We cannot rule out that these were caused by (non-cultured) P. aeruginosa. However, we performed a sensitivity analyses taking into account pneumonias caused by other and unknown pathogens as competing events, to assess if this changed our final estimates. This was not the case. Despite the limitations, this study suggests that previous PA colonization contributes to the development of PA ICU pneumonia. Identifying patients at higher risk for developing subsequent infection is important in case that preventive medication becomes available, but also when empirical therapy needs to be started.

Conclusion

In this study the incidence of P. aeruginosa ICU pneumonia was 1.34%. Hazard ratios for PA colonized patients compared to non-colonized to develop PA ICU pneumonia were 8.8.
  9 in total

1.  Validity analysis of a unique infection surveillance system in the intensive care unit by analysis of a data warehouse built through a workflow-integrated software application.

Authors:  L De Bus; G Diet; B Gadeyne; I Leroux-Roels; G Claeys; K Steurbaut; D Benoit; F De Turck; J Decruyenaere; P Depuydt
Journal:  J Hosp Infect       Date:  2014-04-28       Impact factor: 3.926

2.  Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN.

Authors:  A G Venier; D Gruson; T Lavigne; P Jarno; F L'hériteau; B Coignard; A Savey; A M Rogues
Journal:  J Hosp Infect       Date:  2011-07-07       Impact factor: 3.926

3.  Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance.

Authors:  Laia Fernández-Barat; Miquel Ferrer; Francesca De Rosa; Albert Gabarrús; Mariano Esperatti; Silvia Terraneo; Mariano Rinaudo; Gianluigi Li Bassi; Antoni Torres
Journal:  J Infect       Date:  2016-11-16       Impact factor: 6.072

Review 4.  Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source.

Authors:  Shigeki Fujitani; Hsin-Yun Sun; Victor L Yu; Jeremy A Weingarten
Journal:  Chest       Date:  2011-04       Impact factor: 9.410

5.  Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia.

Authors:  F P Paling; M Wolkewitz; L G M Bode; P M C Klein Klouwenberg; D S Y Ong; P Depuydt; L de Bus; F Sifakis; M J M Bonten; J A J W Kluytmans
Journal:  Clin Microbiol Infect       Date:  2016-09-29       Impact factor: 8.067

6.  Overview of nosocomial infections caused by gram-negative bacilli.

Authors:  Robert Gaynes; Jonathan R Edwards
Journal:  Clin Infect Dis       Date:  2005-08-16       Impact factor: 9.079

7.  Patterns of colonization by Pseudomonas aeruginosa in intubated patients: a 3-year prospective study of 1,607 isolates using pulsed-field gel electrophoresis with implications for prevention of ventilator-associated pneumonia.

Authors:  Jordi Vallés; Dolors Mariscal; Pilar Cortés; Pere Coll; Ana Villagrá; Emili Díaz; Antonio Artigas; Jordi Rello
Journal:  Intensive Care Med       Date:  2004-07-09       Impact factor: 17.440

8.  Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa.

Authors:  Marin H Kollef; Jean Chastre; Jean-Yves Fagon; Bruno François; Michael S Niederman; Jordi Rello; Antoni Torres; Jean-Louis Vincent; Richard G Wunderink; Kerry W Go; Christine Rehm
Journal:  Crit Care Med       Date:  2014-10       Impact factor: 7.598

9.  Pseudomonas aeruginosa Colonization in the Intensive Care Unit: Prevalence, Risk Factors, and Clinical Outcomes.

Authors:  Anthony D Harris; Sarah S Jackson; Gwen Robinson; Lisa Pineles; Surbhi Leekha; Kerri A Thom; Yuan Wang; Michelle Doll; Melinda M Pettigrew; J Kristie Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-01       Impact factor: 3.254

  9 in total
  4 in total

1.  BioFire FilmArray Pneumonia Panel enhances detection of pathogens and antimicrobial resistance in lower respiratory tract specimens.

Authors:  Kosuke Kosai; Norihiko Akamatsu; Kenji Ota; Fujiko Mitsumoto-Kaseida; Kei Sakamoto; Hiroo Hasegawa; Koichi Izumikawa; Hiroshi Mukae; Katsunori Yanagihara
Journal:  Ann Clin Microbiol Antimicrob       Date:  2022-06-04       Impact factor: 6.781

2.  A Data-Driven Framework for Identifying Intensive Care Unit Admissions Colonized With Multidrug-Resistant Organisms.

Authors:  Çaǧlar Çaǧlayan; Sean L Barnes; Lisa L Pineles; Anthony D Harris; Eili Y Klein
Journal:  Front Public Health       Date:  2022-03-17

Review 3.  Empiric Treatment in HAP/VAP: "Don't You Want to Take a Leap of Faith?"

Authors:  Khalil Chaïbi; Gauthier Péan de Ponfilly; Laurent Dortet; Jean-Ralph Zahar; Benoît Pilmis
Journal:  Antibiotics (Basel)       Date:  2022-03-08

4.  Evaluation of GeneXpert PA assay compared to genomic and (semi-)quantitative culture methods for direct detection of Pseudomonas aeruginosa in endotracheal aspirates.

Authors:  Thomas Ewout van der Schalk; Jasmine Coppens; Leen Timbermont; Agata Turlej-Rogacka; Liesbet Van Heirstraeten; Matilda Berkell; Li Yu; Christine Lammens; Basil Britto Xavier; Veerle Matheeussen; Margareta Ieven; Michael McCarthy; Philippe G Jorens; Alexey Ruzin; Mark T Esser; Samir Kumar-Singh; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  Antimicrob Resist Infect Control       Date:  2021-07-23       Impact factor: 4.887

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.